BIOITHAS is a pharmaceutical company based in Alicante, Spain, established in 2017. The company is a globally recognised research centre that specialises in the development of precision probiotics with clinical indications, leveraging the human microbiota as a therapeutic target. BIOITHAS is a leader in the enterocutaneous axis, focusing on inflammatory skin diseases, while also addressing other inflammatory and immunological pathologies. They strive every day to help people improve their health and quality of life.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Contract Research

Bioithas Probiotics is committed to delivering innovative solutions in the pharmaceutical industry, contributing significantly to health advancements. For more information, visit bioithas.com.